arrow_right
Case Studies & Presentations
Case Studies and Presentations
Learn from your peers how they’ve integrated the Envisia Genomic Classifier into their clinical practice.
Envisia Physician Testimonial
Hear from Dr. Nina Maouelainin how she integrated Envisia Genomic Classifier into her clinical practice and the test’s impact on patient management.
Utility of Envisia Genomic Classifier in Multi Disciplinary ILD Management at ATS 2021

Panelists discuss the challenges in making an early accurate diagnosis in patients with diverse Interstitial Lung Diseases (ILD), review the latest published clinical validation and utility data for the Envisia Genomic Classifier, and discuss the role of the Envisia classifier in the diagnosis and prognosis of ILD patients.

 

Clinical Utility of Envisia Genomic Classifier to Improve ILD Diagnostic Confidence
In this webinar, speakers will review the published literature on the Envisia Genomic Classifier and how they have integrated the classifier into their practice.
Detecting Genomic UIP Pattern to Improve ILD Diagnostic Confidence
Hear Dr. Anoop Nambiar review the latest data on the Envisia Genomic Classifier and discuss how he integrates the test into clinical practice.
Hot Topics in ILD Diagnostics
Panelists discuss the key elements of an MDD, the role of the Envisia Genomic Classifier, and the identification of progressive fibrosing ILD (PF-ILD) in this interactive webinar.
  • Envisia Physician Testimonial
    Hear from Dr. Nina Maouelainin how she integrated Envisia Genomic Classifier into her clinical practice and the test’s impact on patient management.
  • Utility of Envisia Genomic Classifier in Multi Disciplinary ILD Management at ATS 2021

    Panelists discuss the challenges in making an early accurate diagnosis in patients with diverse Interstitial Lung Diseases (ILD), review the latest published clinical validation and utility data for the Envisia Genomic Classifier, and discuss the role of the Envisia classifier in the diagnosis and prognosis of ILD patients.

     

  • Clinical Utility of Envisia Genomic Classifier to Improve ILD Diagnostic Confidence
    In this webinar, speakers will review the published literature on the Envisia Genomic Classifier and how they have integrated the classifier into their practice.
  • Detecting Genomic UIP Pattern to Improve ILD Diagnostic Confidence
    Hear Dr. Anoop Nambiar review the latest data on the Envisia Genomic Classifier and discuss how he integrates the test into clinical practice.
  • Hot Topics in ILD Diagnostics
    Panelists discuss the key elements of an MDD, the role of the Envisia Genomic Classifier, and the identification of progressive fibrosing ILD (PF-ILD) in this interactive webinar.
The Envisia classifier detects genomic UIP pattern to improve ILD
diagnostic confidence.

Usual interstitial pneumonia (UIP) is a critical factor in differentiating idiopathic pulmonary fibrosis (IPF) from other interstitial lung diseases (ILDs). The Envisia classifier improves ILD diagnostic and prognostic confidence, and can identify twice as many UIP patients than radiology alone when combined with HRCT.
CONTACT A REP TO ORDER VERACYTE TESTING
Veracyte representatives are happy to assist you and to discuss how to integrate our tests into your practice.
First Name*
Last Name*
Email*
Institution/Practice*
Zip Code*
Which Test Interests You?*
More About You*
Message
CONTACT REP
© 2021 Veracyte, Inc. All rights reserved.